2026-04-14T02:23:06Zhttps://recercat.cat/oai/request

oai:recercat.cat:2072/4766082024-11-04T08:12:40Zcom_2072_98col_2072_378192

Optimization of a home hospitalization program for hematopoietic stem cell transplantation with ehealth integration and clinical pharmacist involvement Moreno Martinez, Maria Estela Riba, Mireia Garcia Cadenas, Irene Esquirol, Albert Yusta, Marta Redondo, Sara De Dios, Anna Portos, José Manuel Aso, Olga Marcos Fendian, Ángel Font, Núria Briones Meijide, Javier Martino Bofarull, Rodrigo Feliu, Anna Universitat Autònoma de Barcelona. Departament de Medicina Care model Chimeric antigen receptor T-cell Clinical pharmacist Ehealth Hematopoietic stem cell transplantation Hospital-based home care Home hospitalization represents an alternative to traditional hospitalization, providing comparable clinical safety for hematological patients. At-home therapies can range from the delivery of intravenous antibiotics to more complex scenarios, such as the care during the early period after hematopoietic stem cell transplantation and chimeric antigen receptor T-cell therapy. Early discharge from conventional hospitalization is feasible and helps reduce hospital resources and waiting lists. The coordinated efforts of multidisciplinary teams, including hematologists, nurses, and pharmacists, ensure patient safety and continuity of care. The traditional model of home hospitalization relies on home visits and telephone consultations with physicians and nurses. However, the use of eHealth technologies, such as MY-Medula, can enhance communication and monitoring, and thereby improve patient outcomes with no additional costs. The active involvement of a clinical pharmacist in home hospitalization programs is essential, not only for the proper logistical management of the medication but also to ensure its appropriateness, optimize treatment, address queries from the team and patients, and promote adherence. In conclusion, the implementation of hematopoietic stem cell transplantation and chimeric antigen receptor T-cell therapy home hospitalization programs that use both an eHealth tool and a multidisciplinary care model can optimize patient care and improve quality of life without increasing healthcare costs. 2024-11-04T08:12:40Z 2024-11-04T08:12:40Z 2024-11-04T08:12:40Z 2024 Article http://hdl.handle.net/2072/476608 Frontiers in immunology ; Vol. 15 (2024), p. 1397115 open access Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra i la creació d'obres derivades, fins i tot amb finalitats comercials, sempre i quan es reconegui l'autoria de l'obra original. https://creativecommons.org/licenses/by/4.0/